HomeNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Previous close
$0.40
Day range
$0.39 - $0.42
Year range
$0.39 - $1.09
Market cap
479.20M USD
Avg Volume
1.70M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 284.00K | -67.73% |
Operating expense | 8.09M | 15.80% |
Net income | -18.31M | -71.91% |
Net profit margin | -6.45K | -432.69% |
Earnings per share | — | — |
EBITDA | -15.32M | -21.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.48M | -59.97% |
Total assets | 28.57M | -13.09% |
Total liabilities | 82.04M | 26.03% |
Total equity | -53.47M | — |
Shares outstanding | 1.21B | — |
Price to book | -6.72 | — |
Return on assets | -139.50% | — |
Return on capital | 1,336.50% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -18.31M | -71.91% |
Cash from operations | -12.41M | -10.38% |
Cash from investing | -239.00K | 82.07% |
Cash from financing | 12.08M | -3.95% |
Net change in cash | 352.00K | 145.48% |
Free cash flow | -5.70M | 93.32% |